| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |